Home
Conditions
Hematologic Neoplasms

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

1,027 public trials 268 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Completed

Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation

NCT00146614

Conditions: Graft Versus Host Disease, Graft vs Host Disease, Hematologic Diseases, +6 more
Locations: Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support

NCT00506857

Conditions: Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +11 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation

NCT00144703

Conditions: Acute Lymphoblastic Leukemia, Bone Marrow Diseases, Graft vs Host Disease, +23 more
Locations: Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

IUdR/BUdR Cell Cycle Labelling

NCT00042250

Conditions: Hematologic Diseases, Hematologic Malignancies, Hematologic Neoplasms, +3 more
Locations: M.D. Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Safety Study of MultiStem® in Patients With Acute Leukemia, Chronic Myeloid Leukemia, or Myelodysplasia

NCT00677859

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +12 more
Locations: Mayo Clinic Hospital Phoenix, Arizona, United States

University Hospitals Case Medical Center Cleveland, Ohio, United States

Oregon State University Medical Center Portland, Oregon, United States

University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Dose Escalation Study of ARQ 621 in Adult Patients With Metastatic Solid Tumors and Hematologic Malignancies

NCT00825487

Conditions: Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +25 more
Locations: Translational Genomics Institute Phoenix, Arizona, United States

Premiere Oncology Santa Monica, California, United States

Boston, Massachusetts, United States

Nevada Cancer Institute Las Vegas, Nevada, United States

View Trial Details

Completed

Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal Infection

NCT01198236

Conditions: Bacterial Infections and Mycoses, Hematologic Diseases, Hematologic Neoplasms, +7 more
Locations: The First Hospital of Zhejiang Medical Colleage Zhejiang University Hangzhou, Zhejiang, China

View Trial Details

Completed

Nonmyeloablative Stem Cell Transplantation With CD8-depleted or Unmanipulated Peripheral Blood Stem Cells (PBSC)

NCT00693927

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations: CHU Sart Tilman Liège, Liege, Belgium

View Trial Details

Completed

Mesenchymal Stem Cell Infusion as Prevention for Graft Rejection and Graft-versus-host Disease

NCT00504803

Conditions: Graft vs Host Disease, Hematologic Diseases, Hematologic Neoplasms, +5 more
Locations: CHU Sart Tilman Liège, Liege, Belgium

View Trial Details

Completed

Study of ENMD-2076 in Patients With Relapsed or Refractory Hematological Malignancies

NCT00904787

Conditions: Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +9 more
Locations: Princess Margaret Hospital Toronto, Ontario, Canada

View Trial Details

Hematologic Neoplasms

Hematologic Neoplasms trial results

Related conditions